Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | HCID 966862 | HCID 966862 | — |
| Reactant | HCID 21088920 | HCID 21088920 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 12150313 | HCID 12150313 | — |
Reaction Steps
317 mg 11-chloromethyl-dibenzo[b,f][1,4]oxazepin are added to 400 mg 2-[3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one and 276 mg potassium carbonate in 4 ml N,N-dimethylformamide. The reaction mixture is stirred for two hours at 80° C. For working up it is combined with water and the precipitate formed is suction filtered. The crude product is purified by chromatography over a silica gel column with methylene chloride/methanol (100:0 to 70:30) as eluant.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08034941B2 |
|---|
| Source dataset | uspto-grants-2011_10 |
|---|
| ORD ID | ord-88d7c911cb67442f98eba3d6a1f0905c |
|---|
| Source note | uspto-grants-2011_10 |
|---|